Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | -3.45% | +11.87% | +11.48% |
04-19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
04-05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.48% | 245M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- Wedbush Lowers Price Target fo 2seventy bio to $27 From $34, Maintains Outperform Rating